A Study to Evaluate Nivolumab in Japanese Participants With Muscle-invasive Urothelial Carcinoma
Clinical trial NCT05779592 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05779592
- Sponsor
- Bristol-Myers Squibb
- Status
- ACTIVE_NOT_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2022-11-23
- Primary completion
- 2029-01-02
- Enrollment
- 400
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.